Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study.
Rikiya TaokaMasaki KamadaKazuyoshi IzumiRyuta TanimotoKei DaizumotoYushi HayashidaKatsutoshi UematsuHironobu AraiTakeshi SanoRyoichi SaitoHiromi HiramaToshihiro KobayashiTomoko HondaYu OsakiYohei AbeHirohito NaitoYoichiro TohiYuki MatsuokaTakuma KatoHomare OkazoeNobufumi UedaMikio SugimotoPublished in: International journal of clinical oncology (2024)
Our results indicated the importance of focusing on enfortumab vedotin-induced neuropathy of the sural nerve to maximize efficacy and improve safety.